Clinical Trial Update: Anti-Restenosis After AMI by Erythropoietin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating erythropoietin to prevent restenosis after an acute myocardial infarction. Sponsor: Kyoto Prefectural University of Medicine; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Kyoto Prefectural University of Medicine | Conditions: Acute Myocardial Infarction | Phase 4 | Status: UNKNOWN